Related references
Note: Only part of the references are listed.Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma
Joel del Bel Padua et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2022)
Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
Chuang Nie et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Loss of cell division cycle-associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma
Xing Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2022)
Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
Yi Chen et al.
FRONTIERS IN PHARMACOLOGY (2022)
Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration
Zhengguang Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
Lianghua Luo et al.
FRONTIERS IN GENETICS (2022)
DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
Min-Yi Lv et al.
FRONTIERS IN GENETICS (2022)
DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer
Xinghao Wang et al.
FRONTIERS IN GENETICS (2022)
DNA Damage Repair and Current Therapeutic Approaches in Gastric Cancer: A Comprehensive Review
Menghui Wang et al.
FRONTIERS IN GENETICS (2022)
DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma
Liping Liang et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
Yang Zhang et al.
BIOSCIENCE REPORTS (2022)
Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer
Shantanu Gupta et al.
SCIENTIFIC REPORTS (2022)
The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma
Quan Li et al.
RESPIRATORY RESEARCH (2022)
MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2
Xiaolong Xu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
Zhen Guo et al.
CELL DEATH & DISEASE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer
Shilang Xiao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
David S. Moura et al.
MOLECULAR ONCOLOGY (2021)
Roles of lncRNA MAGI2-AS3 in human cancers
Liu Kai-xin et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
Danielle Maeser et al.
BRIEFINGS IN BIOINFORMATICS (2021)
TMB or not TMB as a biomarker: That is the question
Alfredo Addeo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics
Jiahui Pan et al.
FRONTIERS IN GENETICS (2021)
DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
Ruixue Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells
Zhangding Wang et al.
RNA BIOLOGY (2020)
Current status of immune checkpoint inhibitors for gastric cancer
Koji Kono et al.
GASTRIC CANCER (2020)
The ATM rs189037 G > A polymorphism is associated with the risk and prognosis of gastric cancer in Chinese individuals: A case-control study
Yali Tao et al.
GENE (2020)
LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a
Dandan Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia
Lijuan Chen et al.
RNA BIOLOGY (2020)
Noncoding RNAs in gastric cancer: implications for drug resistance
Ling Wei et al.
MOLECULAR CANCER (2020)
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Li Yuan et al.
MOLECULAR CANCER (2020)
RAD51 Gene Family Structure and Function
Braulio Bonilla et al.
ANNUAL REVIEW OF GENETICS, VOL 54, 2020 (2020)
Graphical calibration curves and the integrated calibration index (ICI) for survival models
Peter C. Austin et al.
STATISTICS IN MEDICINE (2020)
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation
Jingyuan Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5
Jupeng Yuan et al.
ONCOGENE (2020)
MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer
Yue Yang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Quinn Storozynsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer
Hee Sung Kim et al.
ONCOLOGY LETTERS (2019)
Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF--PD-L1 pathway
Yipin Lv et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Statistical predictions with glmnet
Solveig Engebretsen et al.
CLINICAL EPIGENETICS (2019)
Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer
Wei Li et al.
CELL DEATH & DISEASE (2019)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
DNA mismatch repair in cancer
Marina Baretti et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators
Ben Van Calster et al.
EUROPEAN UROLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Xiangchun Li et al.
JAMA ONCOLOGY (2018)
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha et al.
CLINICS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
LncRNAs in DNA damage response and repair in cancer cells
Min Su et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Mechanisms of DNA Damage, Repair, and Mutagenesis
Nimrat Chatterjee et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)
Intra-tumor heterogeneity from a cancer stem cell perspective
Pramudita R. Prasetyanti et al.
MOLECULAR CANCER (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Michael Goldstein et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Application of ggplot2 to Pharmacometric Graphics
K. Ito et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Peter Bouwman et al.
NATURE REVIEWS CANCER (2012)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)